Cargando…

Strategies for Phosphate Control in Patients With CKD

Hyperphosphatemia is a common complication in patients with chronic kidney disease (CKD), particularly in those requiring renal replacement therapy. The importance of controlling serum phosphate has long been recognized based on observational epidemiological studies that linked increased phosphate l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barreto, Fellype Carvalho, Barreto, Daniela Veit, Massy, Ziad A., Drüeke, Tilman B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698320/ https://www.ncbi.nlm.nih.gov/pubmed/31440695 http://dx.doi.org/10.1016/j.ekir.2019.06.002

Ejemplares similares

Low Turnover Bone Disease in Early CKD Stages
por: Barreto, Fellype Carvalho, et al.
Publicado: (2022)

Comment on Indoxyl Sulfate—Review of Toxicity and Therapeutic Strategies. Toxins 2016, 8, 358
por: Barreto, Fellype C., et al.
Publicado: (2017)

Calcimimetics and outcomes in CKD
por: Drüeke, Tilman B
Publicado: (2013)

Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival
por: Massy, Ziad A., et al.
Publicado: (2012)

Protein-Bound Uremic Toxins: New Insight from Clinical Studies
por: Liabeuf, Sophie, et al.
Publicado: (2011)

Urinary Sodium-to-Potassium Ratio and Blood Pressure in CKD
por: Alencar de Pinho, Natalia, et al.
Publicado: (2020)

Introduction: expanding concepts of chronic kidney disease-mineral and bone disorder (CKD-MBD)
por: Fukagawa, Masafumi, et al.
Publicado: (2013)

Endothelial Microparticles in Uremia: Biomarkers and Potential Therapeutic Targets
por: Favretto, Giane, et al.
Publicado: (2019)

Phosphate, Microbiota and CKD
por: Favero, Chiara, et al.
Publicado: (2021)

Estimated Glomerular Filtration Rate Is a Poor Predictor of the Concentration of Middle Molecular Weight Uremic Solutes in Chronic Kidney Disease
por: Neirynck, Nathalie, et al.
Publicado: (2012)

The Authors Reply
por: Alencar de Pinho, Natalia, et al.
Publicado: (2020)

Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease
por: Kaboré, Jean, et al.
Publicado: (2016)

Update of Brazilian Guidelines for Treatment and Assessment of Chronic Kidney Disease – Mineral and Bone Disorders
por: Carvalho, Aluízio Barbosa, et al.
Publicado: (2021)

The impact of type 2 diabetes on bone metabolism
por: Sanches, Claudia Pinheiro, et al.
Publicado: (2017)

Vitamin D and chronic kidney disease: an uneasy relationship
por: Barreto, Fellype Carvalho, et al.
Publicado: (2020)

FGF23 and Phosphate–Cardiovascular Toxins in CKD
por: Vogt, Isabel, et al.
Publicado: (2019)

Phosphate Balance and CKD–Mineral Bone Disease
por: Sprague, Stuart M., et al.
Publicado: (2021)

Direct, Acute Effects of Klotho and FGF23 on Vascular Smooth Muscle and Endothelium
por: Six, Isabelle, et al.
Publicado: (2014)

The impact of cinacalcet in the mineral metabolism markers of patients on dialysis with severe secondary hyperparathyroidism
por: Bucharles, Sérgio Gardano Elias, et al.
Publicado: (2019)

Phosphate Metabolism in CKD Stages 3–5: Dietary and Pharmacological Control
por: Ketteler, Markus
Publicado: (2011)

Achievement of Low-Density Lipoprotein Cholesterol Targets in CKD
por: Massy, Ziad A., et al.
Publicado: (2019)

How do Uremic Toxins Affect the Endothelium?
por: da Cunha, Regiane Stafim, et al.
Publicado: (2020)

Treatment of Osteoporosis in Chronic Kidney Disease
por: Barreto, Fellype Carvalho, et al.
Publicado: (2021)

The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda
por: Fliser, Danilo, et al.
Publicado: (2011)

Rare inherited kidney diseases: an evolving field in Nephrology
por: da Cunha, Mariana Faucz Munhoz, et al.
Publicado: (2020)

Determination and Modulation of Total and Surface Calcium-Sensing Receptor Expression in Monocytes In Vivo and In Vitro
por: Paccou, Julien, et al.
Publicado: (2013)

Less arterial stiffness in kidney transplant recipients than chronic kidney disease patients matched for renal function
por: Cheddani, Lynda, et al.
Publicado: (2020)

Hypovitaminosis D in chronic kidney disease
por: Bucharles, Sérgio Gardano Elias, et al.
Publicado: (2021)

Bone biopsy in nephrology practice
por: Barreto, Fellype de Carvalho, et al.
Publicado: (2018)

Effects of different phosphate lowering strategies in patients with CKD on laboratory outcomes: A systematic review and NMA
por: Sekercioglu, Nigar, et al.
Publicado: (2017)

Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients
por: Hafez, Gaye, et al.
Publicado: (2023)

Probiotic Intake and Inflammation in Patients With Chronic Kidney Disease: An Analysis of the CKD-REIN Cohort
por: Wagner, Sandra, et al.
Publicado: (2022)

Letter to the Editor: “Nephrocalcinosis and Nephrolithiasis in X-Linked Hypophosphatemic Rickets: Diagnostic Imaging and Risk Factors”
por: Vaisbich, Maria Helena, et al.
Publicado: (2020)

Aluminum Intoxication in Chronic Kidney Disease
por: de Oliveira, Rodrigo Bueno, et al.
Publicado: (2021)

Comparative analysis of the health status of military police officers and firefighters: a cross-sectional study in the State of Paraná, Brazil
por: dos Santos, Alexandra Ramos, et al.
Publicado: (2022)

Renal Manifestations of Fabry Disease: A Narrative Review
por: Silva, Cassiano Augusto Braga, et al.
Publicado: (2021)

Focus on the Possible Role of Dietary Sodium, Potassium, Phosphate, Magnesium, and Calcium on CKD Progression
por: Mazzaferro, Sandro, et al.
Publicado: (2021)

Bone biopsy in chronic kidney disease: still an option?
por: Drueke, Tilman B.
Publicado: (2020)

Effects of the Use of Non-Calcium Phosphate Binders in the Control and Outcome of Vascular Calcifications: A Review of Clinical Trials on CKD Patients
por: Bolasco, Piergiorgio
Publicado: (2011)

Recommendations for the diagnosis and management of Fabry disease in pediatric patients: a document from the Rare Diseases Committee of the Brazilian Society of Nephrology (Comdora-SBN)
por: Vaisbich, Maria Helena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cbco87f0pkcs9noj7039lsn9iv